These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


205 related items for PubMed ID: 11328774

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Penicillin-resistant Streptococcus pneumoniae endocarditis: a case report and review.
    Siegel M, Timpone J.
    Clin Infect Dis; 2001 Mar 15; 32(6):972-4. PubMed ID: 11247720
    [Abstract] [Full Text] [Related]

  • 3. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
    Cottagnoud P, Acosta F, Cottagnoud M, Neftel K, Täuber MG.
    Antimicrob Agents Chemother; 2000 Aug 15; 44(8):2179-81. PubMed ID: 10898696
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis.
    Piper KE, Rouse MS, Ronningen KL, Steckelberg JM, Wilson WR, Patel R.
    Antimicrob Agents Chemother; 2000 Sep 15; 44(9):2554-6. PubMed ID: 10952616
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quinupristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis.
    Trostdorf F, Reinert RR, Schmidt H, Nichterlein T, Stuertz K, Schmitz-Salue M, Sadowski I, Brück W, Nau R.
    J Antimicrob Chemother; 1999 Jan 15; 43(1):87-94. PubMed ID: 10381105
    [Abstract] [Full Text] [Related]

  • 9. Activity of quinupristin/dalfopristin against Streptococcus pneumoniae in vitro and in vivo in the rabbit model of experimental meningitis.
    Tarasi A, Dever LL, Tomasz A.
    J Antimicrob Chemother; 1997 May 15; 39 Suppl A():121-7. PubMed ID: 9511076
    [Abstract] [Full Text] [Related]

  • 10. Antistaphylococcal activities of quinupristin/dalfopristin in vitro across platelet-fibrin matrices and in experimental endocarditis.
    Berthaud N, Huet Y, Diallo N, Desnottes JF.
    J Antimicrob Chemother; 1997 May 15; 39 Suppl A():93-8. PubMed ID: 9511071
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential release of lipoteichoic and teichoic acids from Streptococcus pneumoniae as a result of exposure to beta-lactam antibiotics, rifamycins, trovafloxacin, and quinupristin-dalfopristin.
    Stuertz K, Schmidt H, Eiffert H, Schwartz P, Mäder M, Nau R.
    Antimicrob Agents Chemother; 1998 Feb 15; 42(2):277-81. PubMed ID: 9527772
    [Abstract] [Full Text] [Related]

  • 15. Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model.
    Suntur BM, Yurtseven T, Sipahi OR, Buke C, Buke M.
    Int J Antimicrob Agents; 2005 Sep 15; 26(3):258-60. PubMed ID: 16099624
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
    Bédos JP, Rieux V, Bauchet J, Muffat-Joly M, Carbon C, Azoulay-Dupuis E.
    Antimicrob Agents Chemother; 1998 Apr 15; 42(4):862-7. PubMed ID: 9559797
    [Abstract] [Full Text] [Related]

  • 17. [Antibiotic resistance analysis of Streptococcus pneumoniae isolates from the hospitalized children in Shanxi Children's Hospital from 2012 to 2014].
    Ge LL, Han ZY, Liu AH, Zhu L, Meng JH.
    Zhonghua Er Ke Za Zhi; 2017 Feb 02; 55(2):109-114. PubMed ID: 28173648
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus.
    Sacar M, Sacar S, Cevahir N, Onem G, Teke Z, Asan A, Turgut H, Adali F, Kaleli I, Susam I, Yaylali YT, Baltalarli A.
    Tex Heart Inst J; 2010 Feb 02; 37(4):400-4. PubMed ID: 20844611
    [Abstract] [Full Text] [Related]

  • 20. Treatment of experimental endocarditis due to penicillin-resistant Streptococcus pneumoniae.
    Fernández Guerrero ML, Arbol F, Verdejo C, Fernández Roblas R, Soriano F.
    Antimicrob Agents Chemother; 1994 May 02; 38(5):1103-6. PubMed ID: 8067745
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.